MORTIMER IAN — SEC Form 4 filings
SEC reporting owner CIK 1619961. 10 Form 4 filings on record with FilingPulse; latest filed 2026-03-13.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-03-12 to 2026-03-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 22 legs across 7 filings — 433,879 shares, $23,512,053 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 29.
- Largest priced transaction: sale of 65,000 shares @ $62.06 ($4,033,900) in Xenon Pharmaceuticals Inc., filed 2026-03-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc. (XENE) | PRESIDENT & CEO, Director | 10 | — | 22 legs · 433,879 sh · $23,512,053 | 29 |
Form 4 filings — MORTIMER IAN
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-13 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Option exercise (M): 12,500 · Sale (S): 7,308 @ $55.23 · Option exercise (M): 12,500 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Option exercise (M): 75,000 @ $8.40 · Sale (S): 21,791 @ $58.81 · Sale (S): 31,694 @ $59.88 · Sale (S): 21,515 @ $60.49 · Option exercise (M): 25,000 @ $3.10 · Sale (S): 12,479 @ $59.50 · +15 more | EDGAR |
| 2026-01-09 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Grant/award (A): 350,000 (derivative) @ $0 · Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Option exercise (M): 40,000 @ $7.49 · Sale (S): 37,938 @ $44.40 · Sale (S): 2,062 @ $44.93 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
| 2025-12-09 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Sale (S): 14,375 @ $45.03 · Sale (S): 8,820 @ $45.59 · Sale (S): 2,010 @ $46.32 | EDGAR |
| 2025-12-03 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Sale (S): 97 @ $45.01 | EDGAR |
| 2025-10-01 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Option exercise (M): 25,000 @ $7.69 · Sale (S): 25,000 @ $40.16 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2025-03-13 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Grant/award (A): 275,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-01-27 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Option exercise (M): 16,217 @ $17.76 · Sale (S): 16,217 @ $40.08 · Option exercise (M): 22,468 @ $17.76 · Sale (S): 22,468 @ $40.20 · Option exercise (M): 15,166 @ $17.76 · Sale (S): 15,166 @ $40.46 · +5 more | EDGAR |
| 2024-03-12 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1619961 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →